Hypertension Trial, Recruiting NCT07648706 Sponsor: Sana'a University Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07648706
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who are pregnant with one baby (not twins or more)
  • Women who are between 8 and 18 weeks pregnant
  • Women whose blood test shows low vitamin D levels (specifically below 25 ng/mL)
  • Women who are willing and able to sign a written consent form agreeing to take part
  • Women who are planning to receive their pregnancy care and give birth at Al-Thawra Modern General Hospital

Who may not be able to join:

  • Women who have high blood pressure that is not well controlled
  • Women who are already taking vitamin D supplements before joining the trial
  • Women who have severe long-term kidney disease
  • Women who had diabetes before becoming pregnant
  • Women who have a condition where the immune system attacks the body (such as lupus or similar disorders)
  • Women whose baby has already been found to have a birth defect
  • Women who have a condition called primary hyperparathyroidism, which causes the body to produce too much of a hormone that controls calcium levels (confirm with trial site)
  • Women who have a thyroid condition
  • Women who are taking any medications that affect how the body processes vitamin D or calcium
  • Women who are unable or unwilling to follow the study plan and attend all required check-ups

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Amany Omer Taib, MBBS, Faculty of Medicine and Health Sciences, Sana'a University

Phone: +967775851225

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Sana'a University
Registry
ClinicalTrials.gov
Start date
4 August 2024
Est. completion
1 August 2026

Where this trial is recruiting

Yemen

Primary endpoints

Incidence of Pre-eclampsia events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov